Stories tagged 'Martin Cheever'
6 questions in cancer immunotherapy
From cancer vaccines to engineered T cells, experts weigh in on the big unknowns
March 18, 2016 | by Susan Keown / Fred Hutch News Service
Fred Hutch immunotherapy experts share their perspectives on a few of the big questions in cancer immunotherapy research — and the steps that they and their colleagues are taking to answer them as quickly as they can.
Scratching the surface of a rare skin cancer
Immune-boosting therapy shows promise for advanced Merkel cell carcinoma
Oct. 6, 2015 | By Dr. Rachel Tompa / Fred Hutch News Service
Skin cancer researcher Dr. Paul Nghiem is leading a clinical trial testing the immunotherapy drug pembrolizumab for patients with advanced Merkel cell carcinoma, a rare and aggressive skin cancer. Early results from the trial are showing great promise for these patients.
What Uganda is teaching us about cancer
Fred Hutch-Uganda alliance builds a new cancer center on the shoulders of giants
May 12, 2015 | By Mary Engel / Fred Hutch News Service
"it's been a long, long journey here," said Uganda Cancer Institute physician Dr. Fred Okuku, referring to the grand opening of the UCI-Fred Hutch Cancer Centre on May 21 in Kampala.
Cancer Immunotherapy Trials Network selects member sites
Center-based initiative announces 27 institutional partners in national research effort to accelerate clinical trials of promising cancer immunotherapies
April 11, 2011
Research institutions at 27 sites across North America have been selected as part of the Cancer Immunotherapy Trials Network, based at the Fred Hutchinson Cancer Research Center. A new initiative in immunotherapy, CITN unites top academic immunologists to conduct multicenter research on therapies that boost patients’ own immune systems to fight cancer.
Center awarded $11.5 million for breast cancer research consortium
Porter, Cheever will lead the five-year Seattle-based SPORE in projects including development of targeted treatments for drug-resistant tumors
Nov. 15, 2010 | By Kristen Woodward
The National Cancer Institute has awarded $11.5 million to the Fred Hutchison Cancer Research Center to lead a five-year, Seattle-based breast cancer research consortium. The goal of the endeavor is to positively impact breast cancer prevention, detection, treatment and care of women who have or are at risk for the disease.
Tags: Amanda Paulovich, biomarker, Breast Cancer, cancer consortium, cancer immunotherapy, cancer research, cancer treatment, Clinical Research, David M Hockenbery, fred hutchinson cancer research center, Human Biology, James M Roberts, Kathleen E Malone, Martin Cheever, Peggy Porter, Public Health Sciences, Seattle, Stanley R Riddell
Immunologists’ ‘team science’ honored
Collaborative achievements in T-cell immunotherapies cited
Oct. 11, 2010
Two dozen researchers from the Fred Hutchinson/University of Washington Cancer Consortium received first-ever Team Science awards from the International Society for Biological Therapy of Cancer on Oct. 3 at the organization’s 25th annual meeting in Washington, D.C.
(RSS feeds are best viewed in browsers other than Chrome)
Editor's Picks
Six misconceptions about colorectal cancer
Luke Timmerman to scale Mount Everest for Fred Hutch research
A message from Dr. Gary Gilliland about cancer research in 2018
GIVE NOW &
SAVE LIVES
Story Archive
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Publications
Magazine Archive
Back issues of Hutch Magazine
Financial Reporting
Fiscal highlights & Annual Reports
Science Spotlight
Monthly review of Center-authored papers
Fred Hutch News
Get updates via email.
